Celltrion DiaTrust™ COVID-19 Ag Rapid Test is a rapid test based on lateral flow immunoassay intended for the qualitative detection of nucleocapsid and receptor binding domains (RBDs) from the SARS-CoV-2 spike proteins in human nasopharyngeal swab specimen. Results are for the identification of SARS-CoV-2 nucleocapsid and RBD protein antigen.
iHealth COVID-19 Antigen Rapid Test is the simplest way to detect SARS-CoV-2 nucleocapsid protein antigen. It only takes 4 steps and 15 minutes to complete the test. The test is also non-invasive. You won’t need to collect a sample from deep in your nasal cavity to get accurate results.
A Rapid Immunoassay for the Simultaneous Direct Detection and Differential Diagnosis of SARS-CoV-2, Influenza Type A and Type B Antigen from nasopharyngeal swab specimens
Viruses, such as SARS-CoV-2 (COVID-19), can cause serious health issues and play an important role in molecular biology and biomedical research. Having the right tools is critical for scientific discovery for COVID-19, including the efficient isolation of viral DNA/RNA with high purity and integrity, which is often a challenge.
ARX Sciences Viral Transport Medium is intended for the transport of clinical specimens containing upper respiratory viruses from collection sites for measurement of viral particles in the samples using molecular and antigen assays.